Report Summary
The global Artificial Heart Valve market is valued at million US$ in 2020 and will reach million US$ by the end of 2027, growing at a CAGR of during 2021-2027. The objectives of this study are to define, segment, and project the size of the Artificial Heart Valve market based on company, product type, end user and key regions.
This report studies the global market size of Artificial Heart Valve in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Artificial Heart Valve in these regions.
This research report categorizes the global Artificial Heart Valve market by top players/brands, region, type and end user. This report also studies the global Artificial Heart Valve market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Edwards Lifesciences
Medtronic
St. Jude Medical
Boston Scientific Corporation
Livanova
Symetis
Jenavalve Technology
Cryolife
TTK Healthcare Limited
Colibri Heart Valve
Lepu Medical Technology
Braile Biomédica
Micro Interventional
Autotissue Berlin GmbH
Market size by Product
Transcatheter Heart Valves
Tissue Heart Valves
Mechanical Heart Valves
Market size by End User
Hospital
Clinic
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Artificial Heart Valve market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2020, and forecast to 2027.
To understand the structure of Artificial Heart Valve market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Artificial Heart Valve companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Artificial Heart Valve submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Artificial Heart Valve are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2020
Forecast Year 2021 to 2027
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Artificial Heart Valve market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2020 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table Of Contents
Table of Contents
1 Study Coverage
1.1 Artificial Heart Valve Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Artificial Heart Valve Market Size Growth Rate by Product
1.4.2 Transcatheter Heart Valves
1.4.3 Tissue Heart Valves
1.4.4 Mechanical Heart Valves
1.5 Market by End User
1.5.1 Global Artificial Heart Valve Market Size Growth Rate by End User
1.5.2 Hospital
1.5.3 Clinic
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Artificial Heart Valve Market Size
2.1.1 Global Artificial Heart Valve Revenue 2017-2027
2.1.2 Global Artificial Heart Valve Sales 2017-2027
2.2 Artificial Heart Valve Growth Rate by Regions
2.2.1 Global Artificial Heart Valve Sales by Regions
2.2.2 Global Artificial Heart Valve Revenue by Regions
3 Breakdown Data by Manufacturers
3.1 Artificial Heart Valve Sales by Manufacturers
3.1.1 Artificial Heart Valve Sales by Manufacturers
3.1.2 Artificial Heart Valve Sales Market Share by Manufacturers
3.1.3 Global Artificial Heart Valve Market Concentration Ratio (CR5 and HHI)
3.2 Artificial Heart Valve Revenue by Manufacturers
3.2.1 Artificial Heart Valve Revenue by Manufacturers (2017-2020)
3.2.2 Artificial Heart Valve Revenue Share by Manufacturers (2017-2020)
3.3 Artificial Heart Valve Price by Manufacturers
3.4 Artificial Heart Valve Manufacturing Base Distribution, Product Types
3.4.1 Artificial Heart Valve Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Artificial Heart Valve Product Type
3.4.3 Date of International Manufacturers Enter into Artificial Heart Valve Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Product
4.1 Global Artificial Heart Valve Sales by Product
4.2 Global Artificial Heart Valve Revenue by Product
4.3 Artificial Heart Valve Price by Product
5 Breakdown Data by End User
5.1 Overview
5.2 Global Artificial Heart Valve Breakdown Data by End User
6 North America
6.1 North America Artificial Heart Valve by Countries
6.1.1 North America Artificial Heart Valve Sales by Countries
6.1.2 North America Artificial Heart Valve Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Artificial Heart Valve by Product
6.3 North America Artificial Heart Valve by End User
7 Europe
7.1 Europe Artificial Heart Valve by Countries
7.1.1 Europe Artificial Heart Valve Sales by Countries
7.1.2 Europe Artificial Heart Valve Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Artificial Heart Valve by Product
7.3 Europe Artificial Heart Valve by End User
8 Asia Pacific
8.1 Asia Pacific Artificial Heart Valve by Countries
8.1.1 Asia Pacific Artificial Heart Valve Sales by Countries
8.1.2 Asia Pacific Artificial Heart Valve Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Artificial Heart Valve by Product
8.3 Asia Pacific Artificial Heart Valve by End User
9 Central & South America
9.1 Central & South America Artificial Heart Valve by Countries
9.1.1 Central & South America Artificial Heart Valve Sales by Countries
9.1.2 Central & South America Artificial Heart Valve Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Artificial Heart Valve by Product
9.3 Central & South America Artificial Heart Valve by End User
10 Middle East and Africa
10.1 Middle East and Africa Artificial Heart Valve by Countries
10.1.1 Middle East and Africa Artificial Heart Valve Sales by Countries
10.1.2 Middle East and Africa Artificial Heart Valve Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Artificial Heart Valve by Product
10.3 Middle East and Africa Artificial Heart Valve by End User
11 Company Profiles
11.1 Edwards Lifesciences
11.1.1 Edwards Lifesciences Company Details
11.1.2 Company Business Overview
11.1.3 Edwards Lifesciences Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2020)
11.1.4 Edwards Lifesciences Artificial Heart Valve Products Offered
11.1.5 Edwards Lifesciences Recent Development
11.2 Medtronic
11.2.1 Medtronic Company Details
11.2.2 Company Business Overview
11.2.3 Medtronic Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2020)
11.2.4 Medtronic Artificial Heart Valve Products Offered
11.2.5 Medtronic Recent Development
11.3 St. Jude Medical
11.3.1 St. Jude Medical Company Details
11.3.2 Company Business Overview
11.3.3 St. Jude Medical Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2020)
11.3.4 St. Jude Medical Artificial Heart Valve Products Offered
11.3.5 St. Jude Medical Recent Development
11.4 Boston Scientific Corporation
11.4.1 Boston Scientific Corporation Company Details
11.4.2 Company Business Overview
11.4.3 Boston Scientific Corporation Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2020)
11.4.4 Boston Scientific Corporation Artificial Heart Valve Products Offered
11.4.5 Boston Scientific Corporation Recent Development
11.5 Livanova
11.5.1 Livanova Company Details
11.5.2 Company Business Overview
11.5.3 Livanova Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2020)
11.5.4 Livanova Artificial Heart Valve Products Offered
11.5.5 Livanova Recent Development
11.6 Symetis
11.6.1 Symetis Company Details
11.6.2 Company Business Overview
11.6.3 Symetis Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2020)
11.6.4 Symetis Artificial Heart Valve Products Offered
11.6.5 Symetis Recent Development
11.7 Jenavalve Technology
11.7.1 Jenavalve Technology Company Details
11.7.2 Company Business Overview
11.7.3 Jenavalve Technology Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2020)
11.7.4 Jenavalve Technology Artificial Heart Valve Products Offered
11.7.5 Jenavalve Technology Recent Development
11.8 Cryolife
11.8.1 Cryolife Company Details
11.8.2 Company Business Overview
11.8.3 Cryolife Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2020)
11.8.4 Cryolife Artificial Heart Valve Products Offered
11.8.5 Cryolife Recent Development
11.9 TTK Healthcare Limited
11.9.1 TTK Healthcare Limited Company Details
11.9.2 Company Business Overview
11.9.3 TTK Healthcare Limited Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2020)
11.9.4 TTK Healthcare Limited Artificial Heart Valve Products Offered
11.9.5 TTK Healthcare Limited Recent Development
11.10 Colibri Heart Valve
11.10.1 Colibri Heart Valve Company Details
11.10.2 Company Business Overview
11.10.3 Colibri Heart Valve Artificial Heart Valve Sales, Revenue and Gross Margin (2017-2020)
11.10.4 Colibri Heart Valve Artificial Heart Valve Products Offered
11.10.5 Colibri Heart Valve Recent Development
11.11 Lepu Medical Technology
11.12 Braile Biomédica
11.13 Micro Interventional
11.14 Autotissue Berlin GmbH
12 Future Forecast
12.1 Artificial Heart Valve Market Forecast by Regions
12.1.1 Global Artificial Heart Valve Sales Forecast by Regions 2019-2025
12.1.2 Global Artificial Heart Valve Revenue Forecast by Regions 2019-2025
12.2 Artificial Heart Valve Market Forecast by Product
12.2.1 Global Artificial Heart Valve Sales Forecast by Product 2019-2025
12.2.2 Global Artificial Heart Valve Revenue Forecast by Product 2019-2025
12.3 Artificial Heart Valve Market Forecast by End User
12.4 North America Artificial Heart Valve Forecast
12.5 Europe Artificial Heart Valve Forecast
12.6 Asia Pacific Artificial Heart Valve Forecast
12.7 Central & South America Artificial Heart Valve Forecast
12.8 Middle East and Africa Artificial Heart Valve Forecast
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Artificial Heart Valve Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
